Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs
- 27 June 2013
- journal article
- research article
- Published by Wiley in Veterinary Ophthalmology
- Vol. 17 (5) , 328-333
Abstract
Objective: To determine the effect of topical naltrexone 0.3% on tear production, corneal sensitivity, and tear film stability in normal brachycephalic dogs.Animals Studied: Twenty‐two normal brachycephalic dogs.Procedures: Measurements of tear production (Schirmer tear test I andII), intraocular pressure (IOP), central corneal sensitivity (CS), and tear film breakup time (TFBUT) were collected at time 0, 1, and 24 h after administration of either naltrexone (NTX) 0.3% or placebo (SV). Naltrexone orSVwas then administered once daily for 1 week, and the above measurements were repeated at 7 days, then again 7 days after discontinuing medication. Owners scored the degree of comfort, redness, rubbing, squinting, and tearing. Serum was collected at time 0, 1, 24 h, and 7 days to determine systemic concentrations.Results: Owners reported no significant change in the degree of comfort, redness, rubbing, squinting, or tearing. Naltrexone was detected in serum of all treated dogs 1‐h postadministration (average: 908 pg/mL, range: 319–1570 pg/mL) and in two dogs at the 1‐week time point. Naltrexone was not detected at the 24‐h time point. There was no significant effect ofNTXonSTT1,STT2,IOP,CS, orTFBUT.Conclusions: Naltrexone 0.3% is well tolerated and safe when applied topically to the eye once daily. Naltrexone 0.3% did not show any significant effects on corneal parameters as measured in this study. At once, daily dosingNTXis systemically absorbed; however, the degree of systemic absorption is not likely to be clinically significant.Keywords
This publication has 36 references indexed in Scilit:
- Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbitsBrain Research Bulletin, 2010
- Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)–OGF receptor (OGFr) axis with naltrexone: A reviewBrain Research Bulletin, 2010
- Dry Eye Reversal and Corneal Sensation Restoration With Topical Naltrexone in Diabetes MellitusArchives of Ophthalmology (1950), 2009
- Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic ratsExperimental Eye Research, 2009
- Neural regulation of lacrimal gland secretory processes: Relevance in dry eye diseasesProgress in Retinal and Eye Research, 2009
- Corneal innervation in mesocephalic and brachycephalic dogs and cats: assessment using in vivo confocal microscopyVeterinary Ophthalmology, 2008
- Prevention of Exuberant Granulation Tissue and Neovascularization in the Rat Cornea by NaltrexoneArchives of Ophthalmology (1950), 2008
- The MyofibroblastThe American Journal of Pathology, 2007
- Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epitheliumBrain Research Bulletin, 2007
- Biomicroscopy of the tear film: the tear film of the pekingese dog1989